Gary E. Gallick
Impact in
- Oncology top 0.5%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Cancer Research top 1%
Papers in
- Oncology 69
- Cancer Cells and Metastasis 16
- HER2/EGFR in Cancer Research 13
- Pancreatic and Hepatic Oncology Research 13
-
- Cancer Mechanisms and Therapy 23
- Co-authors
- Nila U. Parikh (34 shared papers)Lee M. Ellis (21 shared papers)Justin M. Summy (18 shared papers)James L. Abbruzzese (6 shared papers)Michael P. Kim (5 shared papers)Douglas B. Evans (8 shared papers)Huamin Wang (4 shared papers)Serk In Park (7 shared papers)
- Journals
- Cancer Research (17 papers)Clinical Cancer Research (13 papers)Oncogene (8 papers)Journal of Cellular Physiology (5 papers)Molecular Cancer Therapeutics (5 papers)
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Gary E. Gallick
200 papers receiving 15k citations
Gary E. Gallick's Hit Papers
Peers
Comparison fields: 5 of 127
- Oncology 4.8k
- Cancer Research 1.5k
- Immunology and Allergy 491
- Molecular Biology 4.8k
- Pathology and Forensic Medicine 1.2k
Countries citing papers authored by Gary E. Gallick
This map shows the geographic impact of Gary E. Gallick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary E. Gallick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary E. Gallick more than expected).
Fields of papers citing papers by Gary E. Gallick
This network shows the impact of papers produced by Gary E. Gallick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary E. Gallick. The network helps show where Gary E. Gallick may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary E. Gallick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 200 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer Hit paper breakdown → | 2009 | 762 |
| 2 | 2002 | 564 | |
| 3 | 2009 | 550 | |
| 4 | 2007 | 384 | |
| 5 | 1993 | 364 | |
| 6 | 2005 | 340 | |
| 7 | 2009 | 323 | |
| 8 | 2001 | 291 | |
| 9 | 2017 | 268 | |
| 10 | 2012 | 255 | |
| 11 | 2017 | 253 | |
| 12 | 2011 | 242 | |
| 13 | 2002 | 228 | |
| 14 | 2008 | 200 | |
| 15 | 2017 | 192 | |
| 16 | 2001 | 191 | |
| 17 | 2013 | 188 | |
| 18 | 2006 | 185 | |
| 19 | 2005 | 184 | |
| 20 | 2002 | 181 |
About Gary E. Gallick
Gary E. Gallick is a scholar working on Oncology, Pathology and Forensic Medicine, Molecular Biology, Pulmonary and Respiratory Medicine and Immunology and Allergy, having authored 200 papers that have together received 15.4k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (37 papers), Prostate Cancer Treatment and Research (29 papers), Cancer Mechanisms and Therapy (23 papers), Angiogenesis and VEGF in Cancer (20 papers), Cancer Cells and Metastasis (16 papers), T-cell and Retrovirus Studies (13 papers), HER2/EGFR in Cancer Research (13 papers) and Pancreatic and Hepatic Oncology Research (13 papers). The work is most often cited by research in Oncology (4.8k citations), Cancer Research (1.5k citations), Immunology and Allergy (491 citations), Molecular Biology (4.8k citations) and Pathology and Forensic Medicine (1.2k citations). Gary E. Gallick has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Nila U. Parikh, Lee M. Ellis, Justin M. Summy, James L. Abbruzzese, Michael P. Kim, Douglas B. Evans, Huamin Wang, Serk In Park, Ralph B. Arlinghaus and David James McConkey. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Oncogene, Journal of Cellular Physiology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.